Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDX · Real-Time Price · USD
5.24
-0.34 (-6.09%)
At close: Dec 5, 2025, 4:00 PM EST
5.00
-0.24 (-4.58%)
After-hours: Dec 5, 2025, 5:06 PM EST
IMDX Market Cap
IMDX has a market cap or net worth of $150.20 million as of December 5, 2025. Its market cap has increased by 250.12% in one year.
Market Cap
150.20M
Enterprise Value
134.64M
1-Year Change
250.12%
Ranking
Category
Stock Price
$5.24
Market Cap Chart
Since January 4, 2016, IMDX's market cap has decreased from $228.70M to $150.20M, a decrease of -34.32%. That is a compound annual growth rate of -4.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 150.20M | 274.56% |
| Dec 31, 2024 | 40.10M | 93.72% |
| Dec 29, 2023 | 20.70M | -45.67% |
| Dec 30, 2022 | 38.10M | -80.96% |
| Dec 31, 2021 | 200.10M | 24.52% |
| Dec 31, 2020 | 160.70M | 37.47% |
| Dec 31, 2019 | 116.90M | 108.38% |
| Dec 31, 2018 | 56.10M | -61.60% |
| Dec 29, 2017 | 146.10M | -27.82% |
| Dec 30, 2016 | 202.40M | -11.50% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |